NEW

Getinge, Cook Medical Reach iCast Distribution Agreement

Getinge and Cook Medical have announced an exclusive sales and distribution agreement for the iCast covered stent system.

Endorail Earns FDA 510(k) clearance: Next-generation magnetic balloon technology optimizes colonoscopy procedural outcomes

Endostart, a pioneering medical device company specializing in gastrointestinal endoscopy solutions, HAS announces a major breakthrough with the FDA 510(k) clearance of its flagship product, Endorail. This achievement represents a significant step forward in advancing...

Survey: Nurse Shortage a Leading Threat to Industry

In honor of Certified Nurses Day, health tech company Carta Healthcare®, whose mission is to harness the value of clinical data, today released the results of a survey about the pain points that health care professionals are currently experiencing. The survey also...

Modular Lab Furniture Systems Meet Needs

UniLine Furniture offerings from HEMCO Corp. include base cabinets, wall cabinets, countertops, sinks, fixtures, base tables, mobile work stations, specialty storage cabinets and peg boards.

Mirragen Advanced Wound Matrix Gains FDA Clearance

ETS Wound Care LLC has announced that Mirragen Advanced Wound Matrix was cleared by the United States Food and Drug Administration (FDA) for treatment of acute and chronic wounds. Mirragen is a fully resorbable borate glass matrix comprised of fibers and beads proven to be highly effective in wound care management.

Mirragen is packed into wounds to manage and control wound fluids, while the resorbable matrix provides an environment for optimal wound healing.

“Anyone who is treating or experiencing discomfort from acute or chronic wounds will immediately recognize the benefits of Mirragen,” said Peggy Earl, BSN, RN, WOCN, a wound care specialist at Phelps County Regional Medical Center in Rolla, Missouri. “Mirragen has the potential to reduce the required number of episodes and duration of wound care treatment, while allowing the body to effectively heal a variety of wounds, both acute and chronic.”

ETS Wound Care plans to make Mirragen commercially available via a controlled domestic market release in early Q2 2017 and available to the broader domestic market in 2018.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X